Pasteurellosis vaccine commercialization: Physiochemical factors for optimum production

• Main Authors: Siti Nur Hazwani Oslan, Tan, Joo Shun, Abdul Hafidz Yusoff, Ahmad Ziad Sulaiman, Mohd Azrie Awang, Azwan Mat Lazim, Lim, Si Jie, Siti Nurbaya Oslan, Mohd Zamri Saad, Arbakariya B. Ariff
• Format: Article
• Language: English; English
• Published: Multidisciplinary Digital Publishing Institute (MDPI) 2022
• Subjects: TP248.13-248.65 Biotechnology
• Online Access: https://eprints.ums.edu.my/id/eprint/34181/1/FULL%20TEXT.pdf; https://eprints.ums.edu.my/id/eprint/34181/2/ABSTRACT.pdf; https://eprints.ums.edu.my/id/eprint/34181/; https://www.mdpi.com/2227-9717/10/7/1248/htm; https://doi.org/10.3390/pr10071248

Pasteurella spp. are Gram-negative facultative bacteria that cause severe economic and animal losses. Pasteurella-based vaccines are the most promising solution for controlling Pasteurella spp. outbreaks. Remarkably, insufficient biomass cultivation (low cell viability and productivity) and lack of knowledge about the cultivation process have impacted the bulk production of animal vaccines. Bioprocess optimization in the shake flask and bioreactor is required to improve process efficiency while lowering production costs. However, its state of the art is limited in providing insights on its biomass upscaling, preventing a cost-effective vaccine with mass-produced bacteria from being developed. In general, in the optimum cultivation of Pasteurella spp., production factors such as pH (6.0–8.2), agitation speed (90–500 rpm), and temperature (35–40 °C) are used to improve production yield. Hence, this review discusses the production strategy of Pasteurella and Mannheimia species that can potentially be used in the vaccines for controlling pasteurellosis. The physicochemical factors related to operational parameter process conditions from a bioprocess engineering perspective that maximize yields with minimized production cost are also covered, with the expectation of facilitating the commercialization process.